ISSN 0975-3583

Journal of Cardiovascular Disease Research

    Drug-Eluting Stents versus Bare-Metal Stents in Large Coronary Arteries: 8 years follow up

    Roopesh Singhal, Zeeshan Mansuri
    JCDR. 2024: 182-195


    Background: Drug-eluting stents (DESs) have been shown to reduce the risk of restenosis and other adverse cardiac events after percutaneous coronary intervention (PCI) as compared with bare-metal stents (BMSs). However, the superiority of DES over BMS has been questioned in large vessels. We evaluated the risks and benefits of the use of DES versus BMS in patients who undergo stenting of large coronary arteries (≥3.5 mm) up to 8 year follow-up.


    » PDF

    Volume & Issue

    Volume 15 Issue 5